CARAEGIS THERAPEUTICS Trademark
Trademark Overview
On Monday, June 8, 2026, a trademark application was filed for CARAEGIS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CARAEGIS THERAPEUTICS trademark a serial number of 99871647. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, June 8, 2026. This trademark is owned by CARaegis Therapeutics, Inc.. The CARAEGIS THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Medical and scientific research services in the field of CAR-T cell therapy; pre-clinical research and development in the field of cell therapy, immunotherapy, oncology, and autoimmune diseases; biotechnology research; research in the field of cell engineering and genetic engineering technology; research and development in the field of cellular immunotherapy; providing medical and scientific research information in the fields of CAR-T cell therapy, cell therapy, immunotherapy, oncology, and genetic engineering; development of pharmaceuticals for cell and gene therapies; cell culture services for others for biomanufacturing; culturing of cells for others for scientific research purposes
General Information
| Serial Number | 99871647 |
| Word Mark | CARAEGIS THERAPEUTICS |
| Filing Date | Monday, June 8, 2026 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Monday, June 8, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| NOT AVAILABLE | "Therapeutics" |
| Pseudo Mark | CARA AEGIS THERAPEUTICS |
| Goods and Services | Medical and scientific research services in the field of CAR-T cell therapy; pre-clinical research and development in the field of cell therapy, immunotherapy, oncology, and autoimmune diseases; biotechnology research; research in the field of cell engineering and genetic engineering technology; research and development in the field of cellular immunotherapy; providing medical and scientific research information in the fields of CAR-T cell therapy, cell therapy, immunotherapy, oncology, and genetic engineering; development of pharmaceuticals for cell and gene therapies; cell culture services for others for biomanufacturing; culturing of cells for others for scientific research purposes |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 8, 2026 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | CARaegis Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Buffalo, NY 14263
US |
Trademark Events
| Event Date | Event Description |
| Monday, June 8, 2026 | NEW APPLICATION ENTERED |
| Monday, June 8, 2026 | APPLICATION FILING RECEIPT MAILED |
